Novo Nordisk Expands Irish Plant, Elects Employee Board Representatives
Novo Nordisk elects four employee board representatives and invests €400+ million expanding Irish GLP-1 manufacturing capacity, signaling confidence in sustained demand.
NVOmanufacturing expansioncapital investment